AIA Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51M Sell
55,397
-2,227
-4% -$2.26M 0.74% 20
2025
Q4
$61.9M Buy
57,624
+10,661
+23% +$10.2M 0.93% 18
2025
Q3
$35.8M Buy
46,963
+12,150
+35% +$9.04M 0.63% 22
2025
Q2
$27.1M Buy
34,813
+1,243
+4% +$966K 0.59% 34
2025
Q1
$27.7M Buy
33,570
+6,880
+26% +$5.72M 0.68% 29
2024
Q4
$20.6M Buy
26,690
+5,530
+26% +$4.58M 0.5% 37
2024
Q3
$18.7M Buy
21,160
+1,796
+9% +$1.61M 0.48% 36
2024
Q2
$17.5M Buy
19,364
+2,020
+12% +$1.62M 0.51% 32
2024
Q1
$13.5M Sell
17,344
-375
-2% -$267K 0.44% 32
2023
Q4
$10.3M Buy
17,719
+467
+3% +$273K 0.42% 33
2023
Q3
$9.27M Buy
17,252
+2,150
+14% +$1.11M 0.45% 34
2023
Q2
$7.08M Buy
15,102
+101
+0.7% +$42.4K 0.34% 35
2023
Q1
$5.15M Buy
15,001
+1,829
+14% +$617K 0.28% 37
2022
Q4
$4.82M Sell
13,172
-772
-6% -$274K 0.29% 36
2022
Q3
$4.51M Sell
13,944
-3,318
-19% -$1.05M 0.3% 40
2022
Q2
$5.6M Sell
17,262
-5,247
-23% -$1.57M 0.3% 41
2022
Q1
$6.45M Buy
22,509
+11,561
+106% +$2.98M 0.28% 37
2021
Q4
$3.02M Buy
10,948
+9,636
+734% +$2.44M 0.14% 73
2021
Q3
$303K Buy
1,312
+7
+0.5% +$1.73K 0.02% 217
2021
Q2
$306K Buy
+1,305
New +$262K 0.02% 178
2021
Q1
Sell
-1,719
Closed -$339K 196
2020
Q4
$339K Buy
+1,719
New +$257K 0.04% 147

Other funds holding LLY

AIA Group's LLY Position: Q1 2026 in Review

AIA Group reduced its Eli Lilly (LLY) stake by 3.9% in Q1 2026, selling an estimated $2.26M and leaving 55,397 shares worth $51M. The position accounts for 0.74% of the portfolio, ranked #20.

AIA Group first reported a position in LLY in Q4 2020 and has held it in 21 quarters since. The position peaked at $61.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AIA Group held 55,397 shares of Eli Lilly worth $51M as of Q1 2026.
  • AIA Group sold 2,227 Eli Lilly shares in Q1 2026, an estimated $2.26M.
  • Eli Lilly made up 0.74% of AIA Group's portfolio in Q1 2026, its #20 holding.
  • AIA Group first reported a position in Eli Lilly in Q4 2020 and has held it in 21 quarters since.
  • AIA Group's Eli Lilly position peaked at $61.9M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.